Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CYH
CYH logo

CYH Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Community Health Systems Inc (CYH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
3.380
1 Day change
52 Week Range
4.460
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Community Health Systems Inc (CYH) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 to invest. The stock exhibits mixed signals with no strong upward momentum, weak financial performance, and neutral sentiment from hedge funds and insiders. While there are some positive catalysts, the negative financial trends and lack of strong trading signals suggest holding off on purchasing this stock for now.

Technical Analysis

The stock's technical indicators are mixed. The MACD is negative and expanding downward, suggesting bearish momentum. RSI is neutral at 45.786, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 3.297, with resistance at 3.671. Overall, the technicals do not strongly support a buy decision.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
6

Positive Catalysts

  • The company is optimizing its asset portfolio by selling four Arkansas hospitals for $112 million, which could improve its financial position. Additionally, the stock has shown a 10.2% price change over the past four weeks, indicating some short-term investor interest.

Neutral/Negative Catalysts

  • The company's financial performance in Q4 2025 was weak, with revenue dropping 4.87% YoY, net income plummeting 257.14% YoY, and EPS falling 252.83% YoY. Analysts have mixed ratings, with some lowering price targets and expressing concerns about the hospital sector's post-COVID challenges. Hedge funds and insiders are neutral, indicating no strong institutional confidence.

Financial Performance

In Q4 2025, revenue dropped to $3.106 billion (-4.87% YoY), net income fell to $110 million (-257.14% YoY), and EPS declined to 0.81 (-252.83% YoY). Gross margin increased slightly to 82.13 (+2.00% YoY), but overall financial performance was weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is mixed. UBS raised the price target to $3.70 (Neutral), Truist raised it to $4.50 (Hold), but Wells Fargo lowered it to $2 (Underweight). Analysts are cautious about the hospital sector due to legislative risks and waning post-COVID tailwinds.

Wall Street analysts forecast CYH stock price to rise
3 Analyst Rating
Wall Street analysts forecast CYH stock price to rise
1 Buy
1 Hold
1 Sell
Hold
Current: 3.380
sliders
Low
2
Averages
3.67
High
5
Current: 3.380
sliders
Low
2
Averages
3.67
High
5
UBS
Neutral
maintain
AI Analysis
2026-02-20
Reason
UBS
Price Target
AI Analysis
2026-02-20
maintain
Neutral
Reason
UBS raised the firm's price target on Community Health to $3.70 from $3.60 and keeps a Neutral rating on the shares.
Wells Fargo
Underweight
downgrade
$3 -> $2
2026-01-07
Reason
Wells Fargo
Price Target
$3 -> $2
2026-01-07
downgrade
Underweight
Reason
Wells Fargo lowered the firm's price target on Community Health to $2 from $3 and keeps an Underweight rating on the shares. For managed care organizations, the firm is most constructive on Medicare Advantage with uncertainty high for Medicaid/Exchanges. Wells sees a more difficult backdrop for hospitals in 2026 as post-COVID tailwinds wane and legislative risks near. Distributor debate remains revisions vs. multiples.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CYH
Unlock Now

People Also Watch